Pak Fah Yeow International Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pak Fah Yeow International Limited with three other pharmaceutical manufacturers in North America: Verastem Inc of UNITED STATES (2019 sales of $17.46 million of which 100% was Pharmaceuticals preparation), Xoma Corporation of UNITED STATES ($18.37 million of which 100% was Biopharmaceutical Pro), and Cara Therapeutics Inc which is also based in UNITED STATES ($19.89 million of which 100% was Pharmaceutical).

Sales Analysis. Pak Fah Yeow International Limited reported sales of 18.86 million Bermudian Dollars (US$18.86 million) for the year ending December of 2019. This represents an increase of 4.8% versus 2018, when the company's sales were 17.99 million Bermudian Dollars. Despite this increase, sales are still well below the level achieved in 2017, when Pak Fah Yeow International Limited reported sales of 22.87 million Bermudian Dollars. Sales of Treasury Investment saw an increase that was more than double the company's growth rate: sales were up 93.2% in 2019, from 66,214.02 Bermudian Dollars to 127,905.30 Bermudian Dollars.